Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia.

J Health Popul Nutr · 2025 · PMC11959848 · PMID 40165298

Europe PMC DOI

hedged sentences

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

a decreasing trendp < 0.01actually significant

There was a slight increasing tendency in DDDc of Dasatinib in tertiary hospitals ( p < 0.01), and a decreasing trend in DDDc of Nilotinib in primary hospitals ( p < 0.01).

also in 25,969 other papers

an increasing trendp < 0.01actually significant

The expenditure of Nilotinib showed an increasing trend before the NVBP in tertiary hospitals ( p < 0.01) and in primary hospitals ( p < 0.05).

also in 31,969 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.